Tirzepatide as an adjunct to automated insulin delivery
What this study tests
Swiss randomized phase 3 study testing tirzepatide as an add-on to usual care in adults with type 1 diabetes using automated insulin delivery.
Editorial review: .
Registry checked: 2026-09-17. Registry’s own update: 2026-01-26.
Most recent recorded citation date: 2026-01-26. Only explicit date metadata is included; an undated citation may be newer. This does not mean every claim was reviewed on that date.
Trial status, labels and access can change between reviews. How we review the evidence · How to read the evidence
Evidence at a glance
- Who can enter the study?
- Adults aged 18-65 with type 1 diabetes. Registered eligibility ↗Enrollment criteria describe who may enter. They do not establish who was analyzed or the denominator for a reported result.
- Reported benefit and results
- No results posted. The registry still lists the study as recruiting even though its estimated June 2026 primary and study-completion dates have passed; the record was last updated on 26 January 2026, so its timeline may be stale.Read the result sources and their limitations →
- Important harms
- Read the reported results, safety discussion and original sources. A separate harms summary is not available; this does not establish safety.
- Research access and approval
- Study regions: Other regions. A trial listing does not establish product approval or current recruitment at a particular site. Check the study’s current entry requirements.
- What remains uncertain?
- Read the full discussion and original sources for study limitations. Planned endpoints and completion dates are not results.
Research status alone does not establish approval, clinical benefit or local availability.
Primary endpoints
- Change in time-in-range at week 16
The full picture
This record has no longer discussion. Use the study criteria, reported results and original sources on this page to assess what is known and what remains unresolved.
Sources
- [1]GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes · Trial registry · 2026-01-26 — RECRUITING; estimated n=42. Estimated primary and study completion were June 2026, now passed without posted results; the registry itself has not been updated since 26 January 2026.